← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2013-07-03

Drug application

FDA Application #

ANDA076672

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

Gabapentin

Active ingredients

GABAPENTIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

TARO

First approval

2013-07-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown